Entry |
|
Name |
Efferocytosis - Hipposideros armiger (great roundleaf bat) |
Class |
Cellular Processes; Transport and catabolism
|
Pathway map |
|
Organism |
Hipposideros armiger (great roundleaf bat) [GN: hai]
|
Gene |
109371278 | ABCA1; ATP-binding cassette sub-family A member 1 isoform X1 [KO:K05641] |
109381836 | NFATC2; nuclear factor of activated T-cells, cytoplasmic 2 [KO:K17332] |
109383198 | NFATC1; nuclear factor of activated T-cells, cytoplasmic 1 isoform X1 [KO:K04446] |
109389408 | NFATC3; nuclear factor of activated T-cells, cytoplasmic 3 isoform X1 [KO:K17333] |
109393596 | NFATC4; nuclear factor of activated T-cells, cytoplasmic 4 isoform X1 [KO:K17334] |
109372278 | ARNT; aryl hydrocarbon receptor nuclear translocator isoform X1 [KO:K09097] |
109384577 | PPARG; peroxisome proliferator-activated receptor gamma isoform X1 [KO:K08530] |
109388316 | CREB1; cyclic AMP-responsive element-binding protein 1 isoform X1 [KO:K05870] |
109372542 | CAMK2G; calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X1 [KO:K04515] [EC:2.7.11.17] |
109373019 | CAMK2B; calcium/calmodulin-dependent protein kinase type II subunit beta isoform X1 [KO:K04515] [EC:2.7.11.17] |
109375001 | CAMK2A; calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X1 [KO:K04515] [EC:2.7.11.17] |
109390284 | CAMK2D; calcium/calmodulin-dependent protein kinase type II subunit delta isoform X1 [KO:K04515] [EC:2.7.11.17] |
109388895 | TIMD4; T-cell immunoglobulin and mucin domain-containing protein 4 isoform X1 [KO:K26936] |
109371509 | LOW QUALITY PROTEIN: hepatitis A virus cellular receptor 1 homolog [KO:K20413] |
109388907 | HAVCR2; hepatitis A virus cellular receptor 2 isoform X1 [KO:K20414] |
109373121 | AGER; advanced glycosylation end product-specific receptor isoform X1 [KO:K19722] |
109384807 | BCAR1; breast cancer anti-estrogen resistance protein 1 isoform X1 [KO:K05726] |
109389817 | ELMO1; engulfment and cell motility protein 1 isoform X1 [KO:K12366] |
109373152 | ADAM9; disintegrin and metalloproteinase domain-containing protein 9 isoform X1 [KO:K06834] [EC:3.4.24.-] |
109396736 | C1QA; complement C1q subcomponent subunit A isoform X1 [KO:K03986] |
109390725 | LRP1; prolow-density lipoprotein receptor-related protein 1 isoform X1 [KO:K04550] |
109379031 | MEGF10; multiple epidermal growth factor-like domains protein 10 [KO:K24068] |
109385257 | MEGF11; multiple epidermal growth factor-like domains protein 11 isoform X1 [KO:K24068] |
109386893 | SCARF1; scavenger receptor class F member 1 isoform X1 [KO:K24318] |
109372697 | GULP1; PTB domain-containing engulfment adapter protein 1 isoform X1 [KO:K23285] |
109373394 | TGFBRAP1; transforming growth factor-beta receptor-associated protein 1 [KO:K20177] |
109396809 | VPS8; vacuolar protein sorting-associated protein 8 homolog isoform X1 [KO:K20178] |
109393906 | VPS11; vacuolar protein sorting-associated protein 11 homolog isoform X1 [KO:K20179] |
109384407 | VPS16; vacuolar protein sorting-associated protein 16 homolog isoform X1 [KO:K20180] |
109384086 | VPS18; vacuolar protein sorting-associated protein 18 homolog [KO:K20181] |
109386071 | VPS33A; vacuolar protein sorting-associated protein 33A [KO:K20182] |
109375590 | vacuolar protein sorting-associated protein 41 homolog [KO:K20184] |
109395583 | PQLC2; lysosomal amino acid transporter 1 homolog isoform X1 [KO:K23678] |
109392313 | PBX1; pre-B-cell leukemia transcription factor 1 isoform X1 [KO:K09355] |
109392458 | PPARD; peroxisome proliferator-activated receptor delta [KO:K04504] |
109383412 | SLC2A1; solute carrier family 2, facilitated glucose transporter member 1 [KO:K07299] |
109380317 | PECAM1; platelet endothelial cell adhesion molecule isoform X1 [KO:K06471] |
109377736 | SIGLEC10; sialic acid-binding Ig-like lectin 10 isoform X1 [KO:K06749] |
109384431 | SIRPA; tyrosine-protein phosphatase non-receptor type substrate 1 isoform X1 [KO:K06551] |
|
Compound |
C00019 | S-Adenosyl-L-methionine |
C04230 | 1-Acyl-sn-glycero-3-phosphocholine |
C06124 | Sphingosine 1-phosphate |
C15610 | Cholest-5-ene-3beta,26-diol |
|
Reference |
|
Authors |
Doran AC, Yurdagul A Jr, Tabas I |
Title |
Efferocytosis in health and disease. |
Journal |
|
Reference |
|
Authors |
Zhang J, Ding W, Zhao M, Liu J, Xu Y, Wan J, Wang M |
Title |
Mechanisms of efferocytosis in determining inflammation resolution: Therapeutic potential and the association with cardiovascular disease. |
Journal |
|
Reference |
|
Authors |
Kawano M, Nagata S |
Title |
Efferocytosis and autoimmune disease. |
Journal |
|
Reference |
|
Authors |
Mehrotra P, Ravichandran KS |
Title |
Drugging the efferocytosis process: concepts and opportunities. |
Journal |
|
Reference |
|
Authors |
Park SY, Kim IS |
Title |
Engulfment signals and the phagocytic machinery for apoptotic cell clearance. |
Journal |
|
Reference |
|
Authors |
Kojima Y, Weissman IL, Leeper NJ |
Title |
The Role of Efferocytosis in Atherosclerosis. |
Journal |
|
Related pathway |
|
KO pathway |
|
LinkDB |
|